image: Expression of a small fragment of p115 (green) leads to Cytochrome C (red) release in cells causing cell death. view more
Credit: Albert Einstein College of Medicine
January 14, 2009 – (BRONX, NY) – Scientists at Albert Einstein College of Medicine of Yeshiva University have identified a small intracellular protein that helps cells commit suicide. The finding, reported as the "paper of the week" in the January 16th print issue of the Journal of Biological Chemistry, could lead to drugs for combating cancer and other diseases characterized by overproduction of cells. The research was led by the late Dennis Shields, Ph.D., a professor in Einstein's Department of Developmental and Molecular Biology for 30 years, who died unexpectedly in December.
In response to stress or as a natural part of aging, many cells undergo programmed suicide, also known as apoptosis. Cancer cells often become immortal and dangerous by developing the ability to suppress apoptosis.
A decade ago apoptosis was thought to be directed solely by the nucleus and mitochondria of cells. Dr. Shields' laboratory was the first to show that a cellular organelle known as the Golgi apparatus also plays a role in apoptosis.
The Golgi package proteins and other substances made by cells and direct them to their destination within the cell. A protein called p115 is vital for maintaining the structure of the Golgi. In earlier research, Dr. Shields' group demonstrated that the Golgi's p115 protein splits into two pieces early in apoptosis and that the smaller of these protein fragments—205 amino acids in length—helps to maintain the cell-suicide process.
In the present study, the Einstein researchers identified the smallest region of this p115 protein fragment that is required for apoptosis: a peptide of just 26 amino acids in length that exerts its apoptotic action by traveling to the nucleus.
"Dennis Shields was one of our most outstanding scientists," says E. Richard Stanley, Ph.D., chairman of developmental and molecular biology at Einstein. "His efforts to uncover fundamental mechanisms governing how cells work has led to new ways of thinking about apoptosis, in particular, how the Golgi regulates this process."
The paper, by Shaeri Mukherjee and Dennis Shields, is titled "Nuclear Import is Required for the Pro-apoptotic Function of the Golgi Protein p115" and appeared in JBC Papers in Press on November 21, 2008 and in the January 16, 2009 print issue. Additionally, the journal chose the image from the paper for the cover and spotlighted the study's first author, Shaeri Mukherjee, Ph.D., a former student in the laboratory of Dr. Shields.
About Albert Einstein College of Medicine of Yeshiva University
Albert Einstein College of Medicine of Yeshiva University is one of the nation's premier centers for research, medical education and clinical investigation. It is the home to some 2,000 faculty members, 750 M.D. students, 350 Ph.D. students (including 125 in combined M.D./Ph.D. programs) and 380 postdoctoral investigators. Last year, Einstein received more than $130 million in support from the NIH. This includes the funding of major research centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Through its extensive affiliation network involving five hospital centers in the Bronx, Manhattan and Long Island – which includes Montefiore Medical Center, Einstein's officially designated University Hospital – the College runs one of the largest post-graduate medical training program in the United States, offering approximately 150 residency programs to more than 2,500 physicians in training. For more information, please visit www.aecom.yu.edu.
Journal
Journal of Biological Chemistry